Stock Screener

Show:

Sort

Country

Sector

Risk rating

1

2

3

4

5

6

7

Risk factors

Default risk

1

2

3

4

5

6

7

Volatility

1

2

3

4

5

6

7

Stress test

1

2

3

4

5

6

7

Selling difficulty

1

2

3

4

5

6

7

Country risks

1

2

3

4

5

6

7

Other risks

1

2

3

4

5

6

7

Profitability factors

Valuation

1

2

3

4

5

6

7

Analyst view

1

2

3

4

5

6

7

Performance

1

2

3

4

5

6

7

Profitability

1

2

3

4

5

6

7

Growth

1

2

3

4

5

6

7

Dividends

1

2

3

4

5

6

7

Results: 17

Haw Par Corporation Limited

Adlai Nortye Ltd.

Riverstone Holdings Limited

Raffles Medical Group Ltd

EUDA Health Holdings Limited

Prestige BioPharma Limited

Mobile-health Network Solutions

Q & M Dental Group (Singapore) Limited

$ SAM Holdings

Osteopore Limited

CytoMed Therapeutics Limited

Cuprina Holdings

UG Healthcare Corporation Limited

Basel Medical Group Ltd

Republic Healthcare Limited

MaxWin International Holdings Limited

Cordlife Group Limited

Guru Portfolios

Track the investments of top funds and market legends

Return for Q2 2026:6.65%

Portfolio composition:

Return for Q2 2026:14.99%

Portfolio composition: